☆ 4.5 Editorial Material

Biospecimen banking: The pathway to personalized medicine for patients with cancer

JOURNAL OF SURGICAL ONCOLOGY (2013)

Journal

JOURNAL OF SURGICAL ONCOLOGY

Volume 107, Issue 7, Pages 681-682

Publisher

WILEY

DOI: 10.1002/jso.23309

Keywords

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5

Not enough ratings

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Personalized Approaches to Stroke: One Step Forward for Functional Recovery of Stroke Patients

Won Hyuk Chang

Summary: Personalized medicine plays a crucial role in the treatment and rehabilitation of stroke patients, as stroke is a complex disease and individualized approaches can overcome current limitations and improve functional recovery.

JOURNAL OF PERSONALIZED MEDICINE (2022)

Add to Collection

Review Health Care Sciences & Services

Application of Patient-Derived Cancer Organoids to Personalized Medicine

Masahiro Shiihara, Toru Furukawa

Summary: Cell models play a crucial role in the research and development of cancer therapies. Recent advances in patient-derived cancer organoids have provided a valuable platform for studying cancer biology and personalized medicine, particularly in the field of pancreatobiliary cancer.

JOURNAL OF PERSONALIZED MEDICINE (2022)

Add to Collection

Article Multidisciplinary Sciences

Genomics to select treatment for patients with metastatic breast cancer

Fabrice Andre, Thomas Filleron, Maud Kamal, Fernanda Mosele, Monica Arnedos, Florence Dalenc, Marie-Paule Sablin, Mario Campone, Herve Bonnefoi, Claudia Lefeuvre-Plesse, William Jacot, Florence Coussy, Jean-Marc Ferrero, George Emile, Marie-Ange Mouret-Reynier, Jean-Christophe Thery, Nicolas Isambert, Alice Mege, Philippe Barthelemy, Benoit You, Nawale Hajjaji, Ludovic Lacroix, Etienne Rouleau, Alicia Tran-Dien, Sandrine Boyault, Valery Attignon, Pierre Gestraud, Nicolas Servant, Christophe Le Tourneau, Linda Larbi Cherif, Isabelle Soubeyran, Filippo Montemurro, Alain Morel, Amelie Lusque, Marta Jimenez, Alexandra Jacquet, Anthony Goncalves, Thomas Bachelot, Ivan Bieche

Summary: Cancer progression is driven by genomic alterations. Genomic profiling can help select effective therapies. A study on HER2-non-overexpressing metastatic breast cancer patients showed that targeted therapies matched to genomic alterations can improve progression-free survival, especially for patients with BRCA1/2 mutations.

NATURE (2022)

Add to Collection

Article Immunology

Peptides-Coated Oncolytic Vaccines for Cancer Personalized Medicine

Sara Feola, Salvatore Russo, Beatriz Martins, Alessandra Lopes, Gaelle Vandermeulen, Vinciane Fluhler, Camilla De Giorgi, Manlio Fusciello, Sari Pesonen, Erkko Yloesmaeki, Gabriella Antignani, Jacopo Chiaro, Firas Hamdan, Michaela Feodoroff, Mikaela Groenholm, Vincenzo Cerullo

Summary: Oncolytic viruses (OVs) can work as in situ cancer vaccines by directly lysing cancer cells and releasing tumor antigens. However, this mechanism may not always induce a strong T cell response. Genetically modified OVs encoding tumor antigens or coating OVs with tumor antigens can enhance the priming efficiency. In this study, both approaches were tested and characterized for their efficacy as cancer vaccines. Both genetically modified oncolytic adenovirus and PeptiCRAd elicited T cells-specific anti-tumor responses, but PeptiCRAd showed advantages in fast presentation of tumor antigens and adaptability for personalized cancer vaccines.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Oncology

Case series of outcomes in advanced cancer patients with single pathway alterations receiving N-of-One therapies

Diviya Gupta, Razelle Kurzrock, Suzanna Lee, Ryosuke Okamura, Hyo Jeong Lim, Ki Hwan Kim, Jason K. Sicklick, Shumei Kato

Summary: This study evaluated the impact of N-of-One therapeutic strategies on the outcome of patients with only one genomic alteration or alterations in one oncogenic pathway. The results showed that a subset of cancer patients may benefit from customized therapeutic matching.

NPJ PRECISION ONCOLOGY (2022)

Add to Collection

Article Oncology

Molecular medicine tumor board: whole-genome sequencing to inform on personalized medicine for a man with advanced prostate cancer

Andrew J. Armstrong, Xiaotong Li, Matthew Tucker, Shantao Li, Xinmeng Jasmine Mu, Kenneth Wha Eng, Andrea Sboner, Mark Rubin, Mark Gerstein

Summary: Molecular profiling of cancer is becoming common in oncology care, providing insights and potential treatment targets for patients with metastatic prostate cancer. This case study of a patient with advanced prostate cancer undergoing whole-genome sequencing revealed actionable genomic lesions and highlighted the importance of personalized medicine in cancer treatment. The patient's outstanding response to combined modality treatment showcases the potential benefits of integrating medical oncology and genomics approaches.

PROSTATE CANCER AND PROSTATIC DISEASES (2021)

Add to Collection

Article Oncology

Patient-derived renal cell carcinoma organoids for personalized cancer therapy

Zhichao Li, Haibo Xu, Lei Yu, Jia Wang, Qian Meng, Hongbing Mei, Zhiming Cai, Wei Chen, Weiren Huang

Summary: This research established an effective three-dimensional culture system for generating kidney cancer organoids and successfully generated 33 organoid lines from different subtypes of kidney cancer. These organoids preserved the histological architecture, mutational landscape, and transcriptional profile of the parental tumor tissues, and revealed inter- and intra-tumoral heterogeneity. Additionally, the organoids can be used for drug screening and evaluating the efficacy of immunotherapy.

CLINICAL AND TRANSLATIONAL MEDICINE (2022)

Add to Collection

Review Nutrition & Dietetics

Personalized Nutritional Therapy Based on Blood Data Analysis for Malaise Patients

Minoru Arakaki, Li Li, Toshiyuki Kaneko, Hiromi Arakaki, Hiromi Fukumura, Chihiro Osaki, Maki Yonamine, Yoshitaka Fukuzawa

Summary: This study introduces a personalized nutritional therapy based on blood data analysis, which has the potential to help patients with pre-disease conditions or undiagnosed malaise recover from their symptoms.

NUTRIENTS (2021)

Add to Collection

Review Oncology

Proteomics, Personalized Medicine and Cancer

Miao Su, Zhe Zhang, Li Zhou, Chao Han, Canhua Huang, Edouard C. Nice

Summary: Cancer is a major global public health issue and personalized/precision medicine plays a crucial role in its diagnosis and treatment. Research focuses on cancer biomarkers, the impact of the microbiome, the application of emerging omics technologies, and future prospects.

CANCERS (2021)

Add to Collection

Review Oncology

Organoid technology for personalized pancreatic cancer therapy

Axel Bengtsson, Roland Andersson, Jonas Rahm, Karthik Ganganna, Bodil Andersson, Daniel Ansari

Summary: This review outlines the most important challenges in exploiting organoid platforms for drug discovery and clinical applications. Some of these challenges may be overcome by novel methods under investigation, such as 3D bioprinting systems, microfluidic systems, optical metabolic imaging, and liquid handling robotics. An optimized organoid workflow inspired by all technical solutions presented in the article is also proposed.

CELLULAR ONCOLOGY (2021)

Add to Collection

Review Oncology

Lung Cancer Organoids: The Rough Path to Personalized Medicine

Rachele Rossi, Maria Laura De Angelis, Eljona Xhelili, Giovanni Sette, Adriana Eramo, Ruggero De Maria, Ursula Cesta Incani, Federica Francescangeli, Ann Zeuner

Summary: Lung cancer is a highly complex disease with significant heterogeneity among patients. Organoids generated from lung tumors are valuable tools in cancer research as they can replicate individual tumor characteristics and aid in the study of the disease and the identification of effective therapies.

CANCERS (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Delivering precision oncology to patients with cancer

Joaquin Mateo, Lotte Steuten, Philippe Aftimos, Fabrice Andre, Mark Davies, Elena Garralda, Jan Geissler, Don Husereau, Iciar Martinez-Lopez, Nicola Normanno, Jorge S. Reis-Filho, Stephen Stefani, David M. Thomas, C. Benedikt Westphalen, Emile Voest

Summary: Precision medicine is reshaping cancer care, but accessibility to all patients remains a challenge. This Perspective highlights the importance of addressing the challenges in implementing precision oncology, including equal access to genomics tests, robust evidence for new drugs and technologies, interpretation of genomics data by physicians, and empowering patients in shared decision-making.

NATURE MEDICINE (2022)

Add to Collection

Article Health Care Sciences & Services

Open Innovation as the Catalyst in the Personalized Medicine to Personalized Digital Medicine Transition

Alfredo Cesario, Marika D'Oria, Irene Simone, Stefano Patarnello, Vincenzo Valentini, Giovanni Scambia

Summary: Personalized medicine utilizes digital and technological solutions to drive innovation and generate new knowledge, while the open innovation paradigm effectively manages transformation in healthcare organizations. This article examines the transition from personalized medicine to personalized digital medicine in a large research hospital, discussing methods, challenges, and results.

JOURNAL OF PERSONALIZED MEDICINE (2022)

Add to Collection

Review Biochemistry & Molecular Biology

3D Bioprinting for Next-Generation Personalized Medicine

Ethan Hau Yin Lam, Fengqing Yu, Sabrina Zhu, Zongjie Wang

Summary: In the past decade, personalized medicine has made significant progress in addressing patient-specific disease complexities and developing individualized treatment strategies. The emergence of 3D bioprinting has provided novel opportunities for personalized medicine, although current bioprinted constructs have limitations in achieving anatomically realistic organs with mature biological functions. This review discusses the principles and realizations of bioprinting, focusing on techniques such as extrusion printing and digital light processing (DLP). It also explores the applications of bioprinted constructs in regenerative medicine and drug discovery. Despite the challenges, bioprinting shows promise as an empowering technology to overcome critical obstacles in personalized medicine.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Add to Collection

Article Information Science & Library Science

Designing Personalized Treatment Plans for Breast Cancer

Wei Chen, Yixin Lu, Liangfei Qiu, Subodha Kumar

Summary: Breast cancer remains a leading cause of cancer deaths among women globally, with contemporary treatment being complex and requiring highly specialized medical professionals. This research proposes a novel framework for decision support in treatment planning for early stage breast cancer patients undergoing radiotherapy, which consistently outperforms existing practices in simulation experiments. Our study contributes to the potential of healthcare information technologies in delivering cost-effective care and provides pragmatic models and tools for clinical care delivery systems.

INFORMATION SYSTEMS RESEARCH (2021)

Add to Collection

Article Surgery

International Center-Level Variation in Utilization of Completion Lymph Node Dissection and Adjuvant Systemic Therapy for Sentinel Lymph Node-Positive Melanoma at Major Referral Centers

Kristy M. Broman, Tasha C. Hughes, Brooke Bredbeck, James Sun, Dennis J. Kirichenko, Michael Carr, Avinash Sharma, Edmund Bartlett, Amanda A. G. Nijhuis, John F. Thompson, Tina J. Hieken, Lisa Kottschade, Jennifer Downs, David E. Gyorki, Emma Stahlie, Alexander van Akkooi, David Ollila, Kristin O'shea, Yun Song, Giorgos Karakousis, Marc Moncrieff, Jenny Nobes, John Vetto, Dale Han, Meghan Hotz, Jeffrey M. Farma, Jeremiah L. Deneve, Martin D. Fleming, Matthew Perez, Kirsten Baecher, Michael Lowe, Roger Olofsson Bagge, Jan Mattsson, Ann Y. Lee, Russell S. Berman, Harvey Chai, Hidde M. Kroon, Juri Teras, Roland M. Teras, Norma E. Farrow, Georgia M. Beasley, Jane Yuet Ching Hui, Lukas Been, Schelto Kruijff, Brandy Sinco, Amod A. Sarnaik, Vernon K. Sondak, Jonathan S. Zager, Lesly A. Dossett

Summary: The aim of this study was to determine trends and variation in the utilization of CLND and adjuvant systemic therapy for SLN-positive melanoma. The study found a decline in CLND and an increase in adjuvant systemic therapy. There was significant variation among treating centers, and location of care contributed significantly to the observed variation.

ANNALS OF SURGERY (2023)

Add to Collection

Article Oncology

Prognostic Significance and Management of Sentinel Nodes in the Triangular Intermuscular Space of Patients with Melanoma

Trine Schoenfeldt, John F. Thompson, Serigne Lo, Krzysztof T. Drzewiecki, Jonathan Stretch, Robyn P. M. Saw, Andrew Spillane, Kerwin Shannon, Roger F. Uren, Annette H. Chakera, Omgo E. Nieweg

Summary: This study aimed to determine the clinical significance of sentinel nodes (SNs) in the triangular intermuscular space (TIS) in patients with melanoma. It found that 11% of patients with melanomas on their upper back had TIS SNs, and retrieval of these SNs was important for accurate staging and to minimize the risk of recurrence in the TIS.

ANNALS OF SURGICAL ONCOLOGY (2023)

Add to Collection

Letter Oncology

Reply to A. Mangla and E. Hindie

Marc D. Moncrieff, Vernon K. Sondak, John F. Thompson, Jonathan S. Zager

JOURNAL OF CLINICAL ONCOLOGY (2023)

Add to Collection

Article Dermatology

IFN-y Signaling Sensitizes Melanoma Cells to BH3 Mimetics

Zizhen Ming, Su Yin Lim, Ashleigh Stewart, Bernadette Pedersen, Elena Shklovskaya, Alexander M. Menzies, Matteo S. Carlino, Richard F. Kefford, Jenny H. Lee, Richard A. Scolyer, Georgina V. Long, Helen Rizos

Summary: Immunotherapy targeting PD-1 and/or CTLA4 can lead to durable responses in some melanoma patients. However, treatment resistance and lack of response are common. This study identifies a vulnerability in melanoma driven by immune cell activity, providing potential strategies for combination therapies.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2023)

Add to Collection

Article Dermatology

Melanomas in children and adolescents: Clinicopathologic features and survival outcomes

Mary-Ann El Sharouni, Robert Rawson, Alison J. Potter, Elizabeth C. Paver, James S. Wilmott, Arjen J. Witkamp, Vigfus Sigurdsson, Paul J. van Diest, Richard A. Scolyer, John F. Thompson, Serigne N. Lo, Carla H. van Gils

Summary: This study evaluated the clinicopathological features and survival of children and adolescents diagnosed with melanoma. The study found that the 10-year recurrence-free survival rates for children and adolescents were 91.5% and 86.4% respectively, with no significant difference. Ulceration status and anatomic site were associated with recurrence-free survival and overall survival.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2023)

Add to Collection

Article Immunology

IFN-γ signature enables selection of neoadjuvant treatment in patients with stage III melanoma

Irene L. M. Reijers, Disha Rao, Judith M. Versluis, Alexander M. Menzies, Petros Dimitriadis, Michel W. Wouters, Andrew J. Spillane, Willem M. C. Klop, Annegien Broeks, Linda J. W. Bosch, Marta Lopez-Yurda, Winan J. van Houdt, Robert V. Rawson, Lindsay G. Grijpink-Ongering, Maria Gonzalez, Sten Cornelissen, Jasper Bouwman, Joyce Sanders, Elsemieke Plasmeijer, Yannick S. Elshot, Richard A. Scolyer, Bart A. van de Wiel, Daniel S. Peeper, Alexander C. J. van Akkooi, Georgina V. Long, Christian U. Blank

Summary: The baseline IFN-gamma signature can be used to select patients who can benefit from anti-PD-1 monotherapy in the DONIMI trial. However, the addition of domatinostat, a class I HDAC inhibitor, does not provide additional benefits in patients receiving neoadjuvant anti-PD-1 +/- anti-CTLA-4. Neoadjuvant ipilimumab + nivolumab shows high pathologic response rates in stage III melanoma, but patients with low intra-tumoral IFN-gamma signatures are less likely to benefit.

JOURNAL OF EXPERIMENTAL MEDICINE (2023)

Add to Collection

Letter Dermatology

Reply to: Estrogen could also play a key role in the development of pediatric melanoma

Mary-Ann El Sharouni, Serigne N. Lo, Richard A. Scolyer, Carla H. van Gils, John F. Thompson

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2023)

Add to Collection

Editorial Material Dermatology

Melanoma In Situ-Getting the Diagnosis and Prognosis Right

Anne E. Cust, Richard A. Scolyer

JAMA DERMATOLOGY (2023)

Add to Collection

Letter Dermatology

Online tools for predicting melanoma survival: Including sentinel node status as a variable improves prediction accuracy

Serigne N. Lo, Alexander H. R. Varey, Mary-Ann El Sharouni, Richard A. Scolyer, John F. Thompson

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2023)

Add to Collection

Meeting Abstract Dermatology

Molecular analysis of primary melanoma T cells identifies patients at risk for metastatic recurrence

W. Pruessmann, J. Rytlewski, J. Wilmott, M. C. Mimh, G. H. Atrill, B. Dyring-Andersen, P. Fields, Q. Zhan, A. J. Colebatch, P. M. Ferguson, J. F. Thompson, K. Kallenbach, E. Yusko, R. Clark, H. Robbins, R. A. Scolyer, T. S. Kupper

EXPERIMENTAL DERMATOLOGY (2023)

Add to Collection

Review Oncology

Development and validation of risk calculators for people with thin melanomas on their skin to predict the likelihood that their cancer will return: a plain language summary of publication

Mary-Ann El Sharouni, Serigne N. Lo, Alexander H. R. Varey, Sjoerd G. Elias, Arjen J. Witkamp, Vigfus Sigurdsson, Karijn P. M. Suijkerbuijk, Paul J. van Diest, Carla H. van Gils, Willeke A. M. Blokx, Richard A. Scolyer, John F. Thompson

Summary: This article summarizes the development of risk calculators for predicting the likelihood of melanoma recurrence in patients with thin melanoma. The calculators were developed and validated using data from Dutch and Australian patients, and were found to accurately predict the risk of melanoma recurrence.

FUTURE ONCOLOGY (2023)

Add to Collection

Article Multidisciplinary Sciences

Uncovering the complex relationship between balding, testosterone and skin cancers in men

Jue-Sheng Ong, Mathias Seviiri, Jean Claude Dusingize, Yeda Wu, Xikun Han, Jianxin Shi, Catherine M. Olsen, Rachel E. Neale, John F. Thompson, Robyn P. M. Saw, Kerwin F. Shannon, Graham J. Mann, Nicholas G. Martin, Sarah E. Medland, Scott D. Gordon, Richard A. Scolyer, Georgina V. Long, Mark M. Iles, Maria Teresa Landi, David C. Whiteman, Stuart Macgregor, Matthew H. Law

Summary: Male-pattern baldness is related to skin cancer, possibly due to increased UV exposure or involvement of androgenic pathways. Genetic analysis shows strong associations between MPB and head and neck skin cancer as well as melanoma, indicating that sun exposure on the scalp, rather than androgens, is the main driver. The lower hair coverage in MPB may explain the higher incidence of melanoma in countries with high ambient UV.

NATURE COMMUNICATIONS (2023)

Add to Collection

Article Oncology

Role of Concurrent Ultrasound Surveillance of Sentinel Node-Positive Node Fields in Melanoma Patients Having Routine Cross-Sectional Imaging

Caroline A. Gjorup, Rachel Woodford, Isabel Li, Matteo S. Carlino, Sydney Ch'ng, David Chung, Edward Hsiao, Serigne N. Lo, Kevin London, Georgina V. Long, Alexander M. Menzies, Omgo E. Nieweg, Thomas E. Pennington, Michael A. Rtshiladze, Robyn P. M. Saw, Richard A. Scolyer, Kerwin F. Shannon, Andrew J. Spillane, Jonathan R. Stretch, John F. Thompson, Alexander H. R. Varey, Alexander C. J. van Akkooi

Summary: Routine concurrent ultrasound surveillance may be unnecessary for sentinel node-positive melanoma patients who receive routine cross-sectional imaging, as most nodal recurrences occur outside the node field and can be detected by both ultrasound and cross-sectional imaging.

ANNALS OF SURGICAL ONCOLOGY (2023)

Add to Collection

No Data Available

Biospecimen banking: The pathway to personalized medicine for patients with cancer

Journal

Publisher

WILEY

Keywords

Categories

Ask authors/readers for more resources

Protocol

Reagent

Authors

I am an author on this paper

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

Export Citation

Share Paper